Stem cell therapies for heart disease come closer to realityOctober 31st, 2008 - 6:25 pm ICT by ANI
Washington, Oct 31 (ANI): Taking a crucial step towards stem cell therapies, scientists have revealed that our bodies” ability to respond to an internal ”mayday” signal may ultimately pave the way for long-awaited regenerative medicine.
The study from the University of Bristol has brought stem cell therapies for heart disease one step closer.
Led by Dr Nicolle Krankel, the researchers have discovered how our bodies initiate DIY rescue and repair mechanisms when blood supply is inadequate, for example in diabetic limbs or in the heart muscle during heart attack.
Usually healthy people experience reduced oxygen supply in certain situations, like, after an injury. The affected tissues release chemical messengers that ”call” to a type of circulating stem cells (EPCs) for help to re-establish blood supply via the growth of new blood vessels.
Now, the researchers have found that kinins, believed to be inflammatory substances, are among the messengers supporting blood vessel growth.
In the study, the researchers found that EPCs respond to kinins by travelling to the target tissue and invading it to assist healing.
In patients with angina, EPCs cannot respond to the distress call because they lack a kinin sensor (the ”kinin receptor”) on their surface. The oxygen-starved tissue is therefore left with reduced blood supply.
However, in heart attack patients they saw that a proportion of the circulating EPCs were able to sense the kinin signal and respond.
“Our findings showed that heart attack patients possess the functional cells needed to repair blood supply to their heart, but they”re hidden amongst a muddle of others, said Dr Krankel.
The researchers purified the kinin-sensitive EPCs from the total stem cell population and went on to create an enriched sample that has huge potential as a powerful regenerative therapy.
Dr Krankel added: “In previous clinical stem cell trials, a mixture of different types of cells were used. We”ve used kinin like a magnet to attract and extract the most effective repair cells from the mass of different types. This enriched sample should increase the therapeutic potential, especially in heart attack patients where quick and efficient treatment is crucial for long term outcome.”
Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation said: “The team have made fascinating discoveries about our DIY repair systems and have translated them into practical use. They”ve intelligently employed the body’’s own strategies to develop a method that may take us a step closer to truly effective stem cell therapies for heart patients.”
The study was published in Circulation Research. (ANI)
- Pain killers retard recovery from heart attack - Apr 09, 2012
- Patients' own stem cells could be used as treatment for their heart disease - Nov 18, 2010
- 'Grafting helps normalise heartbeats' - Aug 06, 2012
- Researchers patch damaged heart with engineered tissue - May 08, 2011
- Scientists grow human heart in lab - Apr 04, 2011
- Researchers turn brain cells into heart cells - Jul 10, 2011
- Human umbilical cord blood cells accelerate diabetic wound healing - Feb 23, 2011
- Lasers to treat human heart after attack - Aug 12, 2011
- Stem cell injections shrink enlarged hearts, improve function - Mar 18, 2011
- Scientists generate pluripotent stem cells from horses - Feb 28, 2011
- 'Smart' adult stem cells repair heart in 'landmark work' - Aug 17, 2010
- Ground-Breaking Dutch Research Finds That 'Spare Tyre' Could Save Lives - Nov 17, 2010
- Researchers find new way to repair damaged heart - Dec 10, 2010
- Long-term pesticide exposure is harmful: STM study - Jun 20, 2012
- Leftover veins can help treat future heart problems - Apr 26, 2010
Tags: blood supply, blood vessel growth, blood vessels, cell population, chemical messengers, distress call, heart attack, heart attack patients, heart disease, heart muscle, mayday, muddle, new blood, nicolle, oxygen supply, regenerative medicine, stem cell, stem cells, target tissue, university of bristol